首页> 外文期刊>Diabetes >Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.
【24h】

Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.

机译:通过适度减轻体重减轻2型糖尿病患者的非酒精性肝脂肪变性,肝胰岛素抵抗和高血糖。

获取原文
获取原文并翻译 | 示例
       

摘要

To examine the mechanism by which moderate weight reduction improves basal and insulin-stimulated rates of glucose metabolism in patients with type 2 diabetes, we used (1)H magnetic resonance spectroscopy to assess intrahepatic lipid (IHL) and intramyocellular lipid (IMCL) content in conjunction with hyperinsulinemic-euglycemic clamps using [6,6-(2)H(2)]glucose to assess rates of glucose production and insulin-stimulated peripheral glucose uptake. Eight obese patients with type 2 diabetes were studied before and after weight stabilization on a moderately hypocaloric very-low-fat diet (3%). The diabetic patients were markedly insulin resistant in both liver and muscle compared with the lean control subjects. These changes were associated with marked increases in IHL (12.2 +/- 3.4 vs. 0.6 +/- 0.1%; P = 0.02) and IMCL (2.0 +/- 0.3 vs. 1.2 +/- 0.1%; P = 0.02) compared with the control subjects. A weight loss of only approximately 8 kg resulted in normalization of fasting plasma glucose concentrations (8.8 +/- 0.5 vs. 6.4 +/- 0.3 mmol/l; P < 0.0005), rates of basal glucose production (193 +/- 7 vs. 153 +/- 10 mg/min; P < 0.0005), and the percentage suppression of hepatic glucose production during the clamp (29 +/- 22 vs. 99 +/- 3%; P = 0.003). These improvements in basal and insulin-stimulated hepatic glucose metabolism were associated with an 81 +/- 4% reduction in IHL (P = 0.0009) but no significant change in insulin-stimulated peripheral glucose uptake or IMCL (2.0 +/- 0.3 vs. 1.9 +/- 0.3%; P = 0.21). In conclusion, these data support the hypothesis that moderate weight loss normalizes fasting hyperglycemia in patients with poorly controlled type 2 diabetes by mobilizing a relatively small pool of IHL, which reverses hepatic insulin resistance and normalizes rates of basal glucose production, independent of any changes in insulin-stimulated peripheral glucose metabolism.
机译:为了研究适度减轻体重改善2型糖尿病患者的基础代谢和胰岛素刺激的葡萄糖代谢率的机制,我们使用(1)H磁共振波谱法评估了2型糖尿病患者的肝内脂质(IHL)和肌内脂质(IMCL)含量。结合使用[6,6-(2)H(2)]葡萄糖的高胰岛素-正常血糖钳来评估葡萄糖的产生速率和胰岛素刺激的外周葡萄糖摄取。在中等体重的低热量低脂饮食(3%)稳定体重之前和之后,对八名2型糖尿病肥胖患者进行了研究。与瘦对照组相比,糖尿病患者的肝脏和肌肉均具有明显的胰岛素抵抗。这些变化与IHL(12.2 +/- 3.4 vs. 0.6 +/- 0.1%; P = 0.02)和IMCL(2.0 +/- 0.3 vs. 1.2 +/- 0.1%; P = 0.02)显着增加有关与控制对象。仅约8 kg的体重减轻导致空腹血浆葡萄糖浓度(8.8 +/- 0.5 vs. 6.4 +/- 0.3 mmol / l; P <0.0005),基础葡萄糖产生速率(193 +/- 7 vs. 153 +/- 10 mg / min; P <0.0005),以及钳夹期间抑制肝葡萄糖产生的百分比(29 +/- 22对99 +/- 3%; P = 0.003)。基础和胰岛素刺激的肝葡萄糖代谢的这些改善与IHL降低81 +/- 4%(P = 0.0009)有关,但胰岛素刺激的外周葡萄糖摄取或IMCL却无明显变化(2.0 +/- 0.3 vs. 1.9 +/- 0.3%; P = 0.21)。总之,这些数据支持以下假设:通过控制相对较小的IHL池,中等体重减轻可使2型糖尿病控制不佳的患者的空腹高血糖正常化,从而逆转肝胰岛素抵抗并使基础葡萄糖生成速率正常化,而与血糖的任何变化无关。胰岛素刺激的外周葡萄糖代谢。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号